Vasonatrin Peptide (VNP) (TFA)

• CAT Number: I044314
• Molecular Formula: C126H199N36O38S3F3
• Molecular Weight: 2979.39
• Purity: ≥95%

Vasonatrin Peptide (VNP) (TFA)（Cat No.:I044314）is a synthetic chimeric peptide composed of elements from atrial natriuretic peptide (ANP) and C-type natriuretic peptide (CNP), designed to harness vasodilatory and natriuretic effects. VNP acts on natriuretic peptide receptors to promote vasodilation, natriuresis, and diuresis, reducing blood pressure and plasma volume. It is primarily studied in cardiovascular research for its potential in treating hypertension, heart failure, and fluid overload conditions. The TFA (trifluoroacetate) form refers to its purification salt, enhancing stability and solubility for experimental use in physiological and pharmacological studies.